WHO suspends hydroxychloroquine’s trial for coronavirus treatment
Published: 10:26 AM, 26 May 2020 Updated: 03:32 PM, 26 May 2020
The World Health Organization (WHO) has suspended the clinical trial of the malaria drug hydroxychloroquine for the treatment of coronavirus and said “the use of these drugs can pose serious health risks to patients.”
Hydroxychloroquine drugs are widely known for the treatment of malaria and autoimmune diseases. United States President Donald Trump has created hype with this drug to prevent the deadly virus. Even Trump is taking regular hydroxychloroquine medications to prevent coronavirus.
But on Monday, WHO’s Director-General Tedros Adhanom Gabrielius said in a statement that evidence of multiple harmful side effects of hydroxychloroquine, including heart problems, had been found. “The drug has been reviewed by the organization’s Data Safety Monitoring Board.”
Based on the negative results, the executive committee of the organization has decided to stop the clinical treatment of hydroxychloroquine for coronavirus patients for the time being, Tedros Adhanom also said.